About
Co-founder and CEO of Tamarind Bio, which provides a computational platform for protein and molecular engineering.
Deniz Kavi @kavi_deniz
@tamarindbio Learn more: https://t.co/ez6GNYjLT3
Jul 14, 2026 Β· β₯ 6 Β· β 1
Deniz Kavi @kavi_deniz
@tamarindbio Similarly, optimization and affinity maturation tools like the ProteinMPNN family also get a large benefit since the base structures the structure-based optimizer is built on have higher accuracy. Evidently, the first breakthrough result doesn't stay at the frontier for long in
Jul 14, 2026 Β· β₯ 5
Deniz Kavi @kavi_deniz
@tamarindbio What does this mean for actual discovery? The obvious part is we get better model structures for historically difficult tasks like AbAg complexes. What is most interesting to me, is the added accuracy to downstream tasks. Most cutting edge de novo design protocols use structure
Jul 14, 2026 Β· β₯ 3
Co-founder & CEO at Tamarind BioYC W24
Intro paths
Deniz went through Y Combinator (Winter 2024) β any YC alum in your network can reach them through the YC community.
Their group partner at YC was Jared Friedman, General Partner at Y Combinator β the partner who ran Tamarind Bio's batch and knows the company first-hand. YC profile β
In turn, Deniz can intro founders to Tamarind Bio's investors below.
